Actively Recruiting
Effect of a Mobile Application on Blood Sugar Testing Compliance in Pregnant Women With Diabetes
Led by Carolyn Zahler-Miller · Updated on 2025-01-31
40
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
This research focuses on pregnant women who have type 2 diabetes or gestational diabetes and need to monitor their blood sugar levels closely. The study aims to compare how well women keep track of their blood sugar using a mobile app versus traditional paper logs. The goal is to see which method leads to better compliance and more time spent with blood sugar levels in the target range. Participants will be assigned to one of two groups randomly. One group will use the OneTouch Reveal mobile app to record their daily blood glucose levels, including fasting and two hours after each meal. The other group will use paper logs to record the same information, which is the usual method in the prenatal clinic. The study will last for four weeks, during which compliance and blood sugar control will be monitored. Throughout the study, participants will record their blood sugar values four times per day and bring their logs or app data to clinic visits. Researchers will track how well participants follow the recording schedule and the percentage of blood sugar readings that stay within the target range. The study includes women at least 18 years old, with a confirmed pregnancy of at least 12 weeks, and diagnosed with type 2 or gestational diabetes. Safety and adherence will be monitored during the study period.
CONDITIONS
Brief Title
Mobile App Logging for Diabetes in Pregnancy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years and older
- Verified intrauterine pregnancy
- At least 12 weeks gestation
- Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus
You will not qualify if you...
- Patients with less than 4 weeks anticipated to be remaining in pregnancy
- Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking
- Type 1 diabetes mellitus
- Non-English speaking patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants log their blood sugar levels daily using either a mobile app or paper logs to manage diabetes during pregnancy.
Weekly visits for 4 weeks
Trial Site Locations
Total: 1 location
1
Augusta University
Augusta, Georgia, United States, 30912
Actively Recruiting
Research Team
R
Rebecca Keipper, MD
C
Carolyn M Zahler-Miller, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here